Hicin Pharmaceutical: The net profit attributable to the parent company in the third quarter was 3.5208 million yuan, a year-on-year increase of 4.15%

On October 22, Hicin Pharmaceutical announced that the company achieved operating revenue of 163 million yuan in the third quarter of 2025, a year-on-year increase of 31.45%; the net profit attributable to shareholders of the listed company was 3.5208 million yuan, a year-on-year increase of 4.15%. In the first three quarters, the company achieved operating revenue of 472 million yuan, a year-on-year increase of 30.80%; the net profit attributable to shareholders of the listed company was 32.6785 million yuan, a year-on-year increase of 16.22%